Germ-line-derived hinge domain p53 mutants have lost apoptotic but not cell cycle arrest functions

Cancer Research

Volumn 58, Issue 10, 1998, Pages 2190-2195

  Aurelio, Oscar N ^a   Cajot, Jean Francois ^a,b   Hua, Mai L H ^a   Khwaja, Zeenat ^a   Stanbridge, Eric J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SWISS INST FOR EXP CANCER RESEARCH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; MUTANT PROTEIN; PROTEIN P53;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; COLON CARCINOMA; CONTROLLED STUDY; FAMILIAL CANCER; GERM LINE; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN DOMAIN; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADULT; APOPTOSIS; CELL CYCLE; GERM-LINE MUTATION; HUMANS; NEOPLASM PROTEINS; PROTEIN CONFORMATION; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032523940     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Hollstein, M. C., Peri, L., Mandard, A. M., Welsh, J. A., Montesano, R., Metcalf, R. A., Bak, M., and Harris, C. C. Genetic analysis of human esophageal tumors from two high incidence geographic areas: frequent p53 base substitutions and absence of ras mutations. Cancer Res., 51: 4102-4106, 1991.
2. Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery C. A., Jr., Butel, J. S., and Bradley, A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature (Lond.), 356: 215-221, 1992.
3. Bader, S. A., Fasching, C., Brodeur, G. M., and Stanbridge, E. J. Dissociation of suppression of tumorigenicity and differentiation in vitro effected by transfer of single human chromosomes into human neuroblastoma cells. Cell Growth Differ., 2: 245-255, 1991.
4. Shaw, P., Bovey, R., Tardy, S., Sahli, R., Sordat, B., and Costa, J. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc. Natl. Acad. Sci. USA, 89: 4495-4499, 1992.
5. Finlay, C. A., Hinds, P. W., and Levine, A. J. The p53 proto-oncogene can act as a suppressor of transformation. Cell, 57: 1083-1093, 1989.
6. Fields, S., and Jang, S. K. Presence of a potent transcription activating sequence in the p53 protein. Science (Washington DC), 249: 1046-1049, 1990.
7. Rowan, S., Ludwig, R. L., Haupt, Y., Bates, S., Lu, X., Oren, M., and Vousden, K. H. Specific loss of apoptotic but not cell-cycle arrest function in a human tumor-derived p53 mutant. EMBO J., 15: 827-838, 1996.
8. Friedlander, P., Haupt, Y., Prives, C., and Oren, M. A mutant p53 that discriminates between p53-responsive genes cannot induce apoptosis. Mol. Cell. Biol., 16: 4961-7491, 1996.
9. Ludwig, R. L., Bates, S., and Vousden, K. H. Differential activation of target cellular promoters by p53 mutants with impaired apoptotic function. Mol. Cell. Biol., 16: 4952-4960, 1996.
10. Haupt, Y., Rowan, S., Shaulian, E., Vousden, K. H., and Oren, M. Induction of apoptosis in HeLa cells by trans-activation-deficient p53. Genes Dev., 9: 2170-2183, 1995.
11. Caamano, J., Ruggeri, B., Momiki, S., Sickler, A., Zhang, S. Y., and Klein-Szanto, A. J. Detection of p53 in primary lung tumors and non-small cell lung carcinoma cell lines. Am. J. Pathol., 139: 839-845, 1991.
12. Kyritsis, A. P., Bondy, M. L., Xiao, M., Berman, E. L., Cunningham, J. E., Lee, P. S., Levin, V. A., and Saya, H. Germline p53 gene mutations in subsets of glioma patients. J. Natl. Cancer Inst., 86: 344-349, 1994.
13. Malkin, D., Jolly, K. W., Barbier, N., Look, A. T., Friend, S. H., Gebhardt, M. C., Andersen, T. I., Borresen, A. L., Li, F. P., Garber, J., and Strong, L. C. Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms. N. Engl. J. Med., 326: 1309-1315, 1992.
14. Cho, Y., Gorina, S., Jeffrey, P. D., and Pavletich, N. P. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science (Washington DC), 265: 346-355, 1994.
15. Jeffrey, P. D., Gorina, S., and Pavletich, N. P. Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms. Science (Washington DC), 267: 1498-1502, 1995.
16. Kuerbitz, S. J., Plunkett, B. S., Walsh, W. V., and Kastan, M. B. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. USA, 89: 7491-7495, 1992.
17. 1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc. Natl. Acad. Sci. USA, 92: 8493-8497, 1995.
18. 1 cyclin-dependent kinases. Cell, 75: 805-816, 1993.
19. el-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817-825, 1993.
20. 1 arrest in human cancer cells. Cancer Res., 55: 5187-5190, 1995.
21. Pietenpol, J. A., Tokino, T., Thiagalingam, S., el-Deiry, W. S., Kinzler, K. W., and Vogelstein, B. Sequence-specific transcriptional activation is essential for growth suppression by p53. Proc. Natl. Acad. Sci. USA, 91: 1998-2002, 1994.
22. Kastan, M. B., Onyekwere, O., Sidransky, D., Vogelstein, B., and Craig, R. W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res., 51: 6304-6311, 1991.
23. Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., and Jacks, T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature (Lond.), 362: 847-849, 1993.
24. Oltvai, Z. N., Milliman, C. L., and Korsmeyer, S. J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell, 74: 609-619, 1993.
25. Miyashita, T., and Reed, J. C. Tumor suppressor p53 is a direct transcriptional activator of the human box gene. Cell, 80: 293-299, 1995.
26. Yin, C., Knudson, C. M., Korsmeyer, S. J., and Van Dyke, T. Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature (Lond.), 385: 637-640, 1997.
27. Knudson, C. M., Tung, K. S., Tourtellotte, W. G., Brown, G. A., and Korsmeyer, S. J. Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science (Washington DC), 270: 96-99, 1995.
28. Shaulsky, G., Goldfinger, N., Ben-Ze'ev, A., and Rotter, V. Nuclear accumulation of p53 protein is mediated by several nuclear localization signals and plays a role in tumorigenesis. Mol. Cell. Biol., 10: 6565-6577, 1990.
29. Wang, X. W., Vermeulen, W., Coursen, J. D., Gibson, M., Lupold, S. E., Forrester, K., Xu, G., Elmore, L., Yeh, H., Hoeijmakers, J. H., and Harris, C. C. The XPB and XPD DNA helicases are components of the p53-mediated apoptosis pathway. Genes Dev., 10: 1219-1232, 1996.
30. Pavletich, N. P., Chambers, K. A., and Pabo, C. O. The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots. Genes Dev., 7: 2556-2564, 1993.